Join us

Oncoinvent presents a unique opportunity to join an expanding pharmaceutical start-up with both R&D and production established in-house which enables both hands-on lab work as well as working with external partners.

The company has solid owners and is in a clinical phase with its lead product (Radspherin®) which is produced in Nydalen.

The candidates should be looking for the energy in a start up with the ambition to make a difference. Successful candidates should be flexible, team-oriented yet able to work independently, and be analytical and results oriented.

If you would like to send us an open application, please send your application and résumé to info@oncoinvent.com

Research Technician, Temporary position (18 months)

Oncoinvent AS is looking for a Research Technician for the Research and Development team at the laboratory facility in Oslo. Today the R&D team consists of more than eight researchers and PhD students. The position is an exciting opportunity to work in an innovative and dynamic company and participate in the development of novel pharmaceuticals.

The company prides itself with an inclusive working environment with a shared vision, in new modern facilities in Nydalen in Oslo, close to the sub way station.

Key responsibilities:

  • Daily maintenance of the research laboratory, including maintaining of equipment and instruments and ordering of laboratory supplies and equipment
  • Maintenance and cultivation of cell lines
  • Assist in planning and performing analyses and research experiments
  • Record, analyse and communicate results of experiments
  • Write and review experimental protocols and reports
  • Organize data and results
  • Troubleshooting of experimental design and analytical methods
  • Maintain and troubleshoot analytical instrumentation as needed
  • Writing of SOPs and other instructional documents
  • The position requires work with radioactive materials. It is therefore important to comply with radiation protection and other health and safety procedures during laboratory experiments.

 

Qualifications and experience:

The holder of this position should have the following documented qualifications and experience:

  • Sc. in chemistry, biotechnology, biology or analytical chemistry.
  • Relevant work experience in cell biology, drug development and/or chemistry
  • Experience with animal research is a benefit
  • Working knowledge in Norwegian and English.
  • A successful candidate should enjoy working in a multidisciplinary team displaying a systematic and analytical approach while being able to plan and perform tasks completing them on time.

Location

The holder of this position will be based at Oncoinvent AS, Gullhaugveien 7, 0484 Oslo. The position will report to the Chief Scientific Officer.

 

About Oncoinvent

Oncoinvent is a privately held Norwegian company based in Nydalen, Oslo. The company is committed to developing novel, innovative products to provide better treatment options for cancer patients.

The Oncoinvent team consists of 40 employees and the company anticipates further growth.

Oncoinvent holds a state-of-the-art manufacturing facility to produce drug products intended for use in pre-clinical and clinical trials. Clinical trials for Oncoinvent’s lead product, Radspherin® are ongoing. For further details on Oncoinvent see www.oncoinvent.com.

The facility holds a GMP certificate from the Norwegian Medical Agency. The approval provides the company with the necessary flexibility and capacity for manufacturing clinical trial material for both patients and trial sites, as well as developing the company further.

The company’s lead product candidate Radspherin® is a novel alpha-emitting radioactive microsphere suspension designed for treatment of micro-metastatic cancers in body cavities. The radium-224 based therapeutic, Radspherin® has shown strong and consistent anticancer activity at doses being essentially non-toxic in preclinical studies. It is anticipated that the product can potentially treat several forms of micro-metastatic cancer.

The development programs of the pipeline of the company include targeted radionuclide therapy for treatment of various solid cancers. The main focus of discovery is on alpha-emitting radionuclides for treatment by regional administration of the drug in body compartments with disseminated solid tumours.

Application deadline:  We are reviewing the applications on a rolling basis.

Please submit your application with a motivational letter stating “why Oncoinvent” and what you can contribute to the position as well as an updated CV. Application without this will not be reviewed further.

Contact: Bjørn Fuglaas, 90775752 – CEO, Life Science Partners AS

Production Technician

Oncoinvent AS is looking for a production technician to strengthen the production team at the company’s manufacturing facility in Oslo. The production team at Oncoinvent is tasked with the development, and GMP compliant production of radiopharmaceuticals. The position is an exciting opportunity to work in an innovative and dynamic start-up company and participate in the development of novel pharmaceuticals.

The successful candidate will, together with the production team and other Oncoinvent staff, drive the manufacture and development of Radspherin® for pre-clinical and early-phase clinical trials.

This position requires work with radioactive materials. A successful candidate is therefore expected to comply with radiation protection and other health and safety procedures during laboratory- and production scale experiments, and GMP production activities.

Key responsibilities:

  • Routine cleaning and environmental monitoring of GMP production rooms, associated technical rooms and general laboratory.
  • Handling of incoming goods, raw material stock keeping and housekeeping including handling of radioactive and non-active waste.
  • Help with maintaining the calibration and qualification status of Oncoinvent’s production facility, equipment and instruments.
  • When necessary, assist in the planning, designing and conducting laboratory- and production scale experiments with the aim of increasing the yield and scale of the Ra-224 drug substance and Radspherin®
  • When necessary, support the writing and review of GMP compliant batch manufacturing records and operating procedures.
  • Develop and maintain a working knowledge in Good Manufacturing Practice (GMP) and participate in annual GMP training.
  • Support production, QC and QA in the investigation and closure of any deviations. Aid production, QC and QA in the implementation of Corrective and Preventative Actions (CAPA).

Qualifications and experience:

The holder of this position should have the following documented qualifications and experience:

  • Bachelor, high school degree in science- or a technical relevant discipline.
  • Working knowledge in Norwegian and English.
  • 1-3 years practical, hands-on experience in the production of pharmaceuticals.

The following experience is desirable:

  • Familiarity with GMP regulations and experience with working in clean rooms is an advantage.
  • A successful candidate will have to be able to work in a multidisciplinary team while being able to plan and perform practical work independently.
  • The production of pharmaceuticals is highly regulated, and a successful candidate will be expected to show attention to detail with respect to planning and documentation of practical work.

Location

The holder of this position will be based at Oncoinvent AS, Gullhaugveien 7, 0484 Oslo. The position will report to the Head of Production.

About Oncoinvent

Oncoinvent is a privately held Norwegian company based in Nydalen, Oslo. The company is committed to developing novel, innovative products to provide better treatment options for cancer patients.

The Oncoinvent team consists of 44 employees and the company anticipates further growth.

Oncoinvent holds a state-of-the-art manufacturing facility to produce drug products intended for use in pre-clinical and clinical trials. Clinical trials for Oncoinvent’s lead product, Radspherin® are ongoing. For further details on Oncoinvent see www.oncoinvent.com.

The facility holds a GMP certificate from the Norwegian Medical Agency. The approval provides the company with the necessary flexibility and capacity for manufacturing clinical trial material for both patients and trial sites, as well as developing the company further.

The company’s lead product candidate Radspherin® is a novel alpha-emitting radioactive microsphere suspension designed for treatment of micro-metastatic cancers in body cavities. The radium-224 based therapeutic, Radspherin® has shown strong and consistent anticancer activity at doses being essentially non-toxic in preclinical studies. It is anticipated that the product can potentially treat several forms of micro-metastatic cancer.

The development programs of the pipeline of the company include targeted radionuclide therapy for treatment of various solid cancers. The main focus of discovery is on alpha-emitting radionuclides for treatment by regional administration of the drug in body compartments with disseminated solid tumours.

Application deadline:  We are reviewing the applications on a rolling basis.

Please submit your application with a motivational letter stating “why Oncoinvent” and what you can contribute to the position as well as an updated CV. Application without this will not be reviewed further.

 Contact:

Bjørn Fuglaas, 90775752
CEO
Life Science Partners AS

Jan Alan Alfheim

Chief Executive Officer

alfheim@oncoinvent.com

+47 464 40 045

Jan A. Alfheim is a business executive with over thirty years’ experience bringing product ideas and technology to the chemical and pharmaceutical markets, from product concept inception through discovery and development phases to final marketing campaign and launch.

With experience in research, project management, business development & partnering, company start-ups, and product launches, Alfheim comes from Nordic Nanovector ASA where he was Chief Executive Officer from 2011 until 2014 and Chief Operating Officer from 2014 to 2016. Prior to working at Nordic Nanovector, he has held various senior roles including Chief Business Officer at Clavis Pharma, President of StemPath Inc, Director of Business Development at Neurochem Inc and Project Director at Nycomed Imaging. Mr. Alfheim holds a MSc from Concordia University and a MBA from McGill University.